175 related articles for article (PubMed ID: 16848649)
21. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
22. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.
Woodward ND; Purdon SE; Meltzer HY; Zald DH
Schizophr Res; 2007 Jan; 89(1-3):211-24. PubMed ID: 17059880
[TBL] [Abstract][Full Text] [Related]
23. Aripiprazole versus placebo for schizophrenia.
Belgamwar RB; El-Sayeh HG
Cochrane Database Syst Rev; 2011 Aug; (8):CD006622. PubMed ID: 21833956
[TBL] [Abstract][Full Text] [Related]
24. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
25. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
26. Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Soares-Weiser K; Béchard-Evans L; Lawson AH; Davis J; Ascher-Svanum H
Eur Neuropsychopharmacol; 2013 Feb; 23(2):118-25. PubMed ID: 22633617
[TBL] [Abstract][Full Text] [Related]
27. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Dossenbach M; Arango-Dávila C; Silva Ibarra H; Landa E; Aguilar J; Caro O; Leadbetter J; Assunção S
J Clin Psychiatry; 2005 Aug; 66(8):1021-30. PubMed ID: 16086618
[TBL] [Abstract][Full Text] [Related]
28. Amisulpride: a review of its use in the management of schizophrenia.
Curran MP; Perry CM
Drugs; 2001; 61(14):2123-50. PubMed ID: 11735643
[TBL] [Abstract][Full Text] [Related]
29. Dose response and dose equivalence of antipsychotics.
Davis JM; Chen N
J Clin Psychopharmacol; 2004 Apr; 24(2):192-208. PubMed ID: 15206667
[TBL] [Abstract][Full Text] [Related]
30. Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature.
Jeste DV; Dolder CR; Nayak GV; Salzman C
Harv Rev Psychiatry; 2005; 13(6):340-51. PubMed ID: 16373328
[TBL] [Abstract][Full Text] [Related]
31. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
[TBL] [Abstract][Full Text] [Related]
32. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics.
Jiang Y; McCombs JS; Park SH
CNS Drugs; 2017 Apr; 31(4):319-326. PubMed ID: 28290080
[TBL] [Abstract][Full Text] [Related]
33. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.
Zhu Y; Krause M; Huhn M; Rothe P; Schneider-Thoma J; Chaimani A; Li C; Davis JM; Leucht S
Lancet Psychiatry; 2017 Sep; 4(9):694-705. PubMed ID: 28736102
[TBL] [Abstract][Full Text] [Related]
35. Dose response and atypical antipsychotics in schizophrenia.
Kinon BJ; Ahl J; Stauffer VL; Hill AL; Buckley PF
CNS Drugs; 2004; 18(9):597-616. PubMed ID: 15222776
[TBL] [Abstract][Full Text] [Related]
36. Quetiapine versus typical antipsychotic medications for schizophrenia.
Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
[TBL] [Abstract][Full Text] [Related]
37. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
38. Risperidone dose for schizophrenia.
Li C; Xia J; Wang J
Cochrane Database Syst Rev; 2009 Oct; (4):CD007474. PubMed ID: 19821422
[TBL] [Abstract][Full Text] [Related]
39. Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.
Bushe CJ; Leonard BE
J Clin Psychiatry; 2007 Nov; 68(11):1682-90. PubMed ID: 18052561
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
